Literature DB >> 19095965

Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle.

Ian Holt1, Virginie Jacquemin, Majid Fardaei, Caroline A Sewry, Gillian S Butler-Browne, Denis Furling, J David Brook, Glenn E Morris.   

Abstract

In myotonic dystrophy, muscleblind-like protein 1 (MBNL1) protein binds specifically to expanded CUG or CCUG repeats, which accumulate as discrete nuclear foci, and this is thought to prevent its function in the regulation of alternative splicing of pre-mRNAs. There is strong evidence for the role of the MBNL1 gene in disease pathology, but the roles of two related genes, MBNL2 and MBNL3, are less clear. Using new monoclonal antibodies specific for each of the three gene products, we found that MBNL2 decreased during human fetal development and myoblast culture, while MBNL1 was unchanged. In Duchenne muscular dystrophy muscle, MBNL2 was elevated in immature, regenerating fibres compared with mature fibres, supporting some developmental role for MBNL2. MBNL3 was found only in C2C12 mouse myoblasts. Both MBNL1 and MBNL2 were partially sequestered by nuclear foci of expanded repeats in adult muscle and cultured cells from myotonic dystrophy patients. In adult muscle nucleoplasm, both proteins were reduced in myotonic dystrophy type 1 compared with an age-matched control. In normal human myoblast cultures, MBNL1 and MBNL2 always co-distributed but their distribution could change rapidly from nucleoplasmic to cytoplasmic. Functional differences between MBNL1 and MBNL2 have not yet been found and may prove quite subtle. The dominance of MBNL1 in mature, striated muscle would explain why ablation of the mouse mbnl1 gene alone is sufficient to cause a myotonic dystrophy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19095965      PMCID: PMC2631334          DOI: 10.2353/ajpath.2009.080520

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression.

Authors:  Jamie M Margolis; Benedikt G Schoser; Melinda L Moseley; John W Day; Laura P W Ranum
Journal:  Hum Mol Genet       Date:  2006-04-19       Impact factor: 6.150

2.  In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts.

Authors:  M Fardaei; K Larkin; J D Brook; M G Hamshere
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

3.  Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.

Authors:  H Seznec; O Agbulut; N Sergeant; C Savouret; A Ghestem; N Tabti; J C Willer; L Ourth; C Duros; E Brisson; C Fouquet; G Butler-Browne; A Delacourte; C Junien; G Gourdon
Journal:  Hum Mol Genet       Date:  2001-11-01       Impact factor: 6.150

4.  Defective satellite cells in congenital myotonic dystrophy.

Authors:  D Furling; L Coiffier; V Mouly; J P Barbet; J L St Guily; K Taneja; G Gourdon; C Junien; G S Butler-Browne
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

5.  Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.

Authors:  A Mankodi; C R Urbinati; Q P Yuan; R T Moxley; V Sansone; M Krym; D Henderson; M Schalling; M S Swanson; C A Thornton
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

6.  Inhibition of muscle differentiation by the novel muscleblind-related protein CHCR.

Authors:  Rachel M Squillace; Dale M Chenault; Edith H Wang
Journal:  Dev Biol       Date:  2002-10-01       Impact factor: 3.582

7.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

8.  Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy.

Authors:  J W Miller; C R Urbinati; P Teng-Umnuay; M G Stenberg; B J Byrne; C A Thornton; M S Swanson
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

9.  Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.

Authors:  C L Liquori; K Ricker; M L Moseley; J F Jacobsen; W Kress; S L Naylor; J W Day; L P Ranum
Journal:  Science       Date:  2001-08-03       Impact factor: 47.728

10.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

Authors:  Majid Fardaei; Mark T Rogers; Helena M Thorpe; Kenneth Larkin; Marion G Hamshere; Peter S Harper; J David Brook
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

View more
  36 in total

1.  Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2.

Authors:  M Giagnacovo; M Malatesta; R Cardani; G Meola; C Pellicciari
Journal:  Histochem Cell Biol       Date:  2012-06-17       Impact factor: 4.304

Review 2.  Myotonic dystrophy: is a narrow focus obscuring the rest of the field?

Authors:  Mani S Mahadevan
Journal:  Curr Opin Neurol       Date:  2012-10       Impact factor: 5.710

3.  Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.

Authors:  Hélène Tran; Nathalie Gourrier; Camille Lemercier-Neuillet; Claire-Marie Dhaenens; Audrey Vautrin; Francisco José Fernandez-Gomez; Ludovic Arandel; Céline Carpentier; Hélène Obriot; Sabiha Eddarkaoui; Lucie Delattre; Edwige Van Brussels; Ian Holt; Glenn E Morris; Bernard Sablonnière; Luc Buée; Nicolas Charlet-Berguerand; Susanna Schraen-Maschke; Denis Furling; Isabelle Behm-Ansmant; Christiane Branlant; Marie-Laure Caillet-Boudin; Nicolas Sergeant
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

4.  Monoclonal antibodies against Muscleblind-like 3, a protein with punctate nuclear localization.

Authors:  Kyung-Soon Lee; K A Lewis; Susan Tom; Elizabeth A Wayner; Edith H Wang
Journal:  Hybridoma (Larchmt)       Date:  2011-04

5.  Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins.

Authors:  Eric T Wang; Neal A L Cody; Sonali Jog; Michela Biancolella; Thomas T Wang; Daniel J Treacy; Shujun Luo; Gary P Schroth; David E Housman; Sita Reddy; Eric Lécuyer; Christopher B Burge
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

6.  Global regulation of alternative splicing during myogenic differentiation.

Authors:  Christopher S Bland; Eric T Wang; Anthony Vu; Marjorie P David; John C Castle; Jason M Johnson; Christopher B Burge; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2010-07-15       Impact factor: 16.971

7.  HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1.

Authors:  Debra A O'Leary; Leonardo Vargas; Orzala Sharif; Michael E Garcia; Yury J Sigal; Siu-Kei Chow; Christian Schmedt; Jeremy S Caldwell; Achim Brinker; Ingo H Engels
Journal:  Curr Chem Genomics       Date:  2010-03-19

8.  Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy.

Authors:  Konstantinos Charizanis; Kuang-Yung Lee; Ranjan Batra; Marianne Goodwin; Chaolin Zhang; Yuan Yuan; Lily Shiue; Melissa Cline; Marina M Scotti; Guangbin Xia; Ashok Kumar; Tetsuo Ashizawa; H Brent Clark; Takashi Kimura; Masanori P Takahashi; Harutoshi Fujimura; Kenji Jinnai; Hiroo Yoshikawa; Mário Gomes-Pereira; Geneviève Gourdon; Noriaki Sakai; Seiji Nishino; Thomas C Foster; Manuel Ares; Robert B Darnell; Maurice S Swanson
Journal:  Neuron       Date:  2012-08-09       Impact factor: 17.173

9.  Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy.

Authors:  Hongqing Du; Melissa S Cline; Robert J Osborne; Daniel L Tuttle; Tyson A Clark; John Paul Donohue; Megan P Hall; Lily Shiue; Maurice S Swanson; Charles A Thornton; Manuel Ares
Journal:  Nat Struct Mol Biol       Date:  2010-01-24       Impact factor: 15.369

Review 10.  Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Authors:  Genevieve Ho; Michael Cardamone; Michelle Farrar
Journal:  World J Clin Pediatr       Date:  2015-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.